pubmed-article:9307857 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C0032961 | lld:lifeskim |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C0521457 | lld:lifeskim |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C0054452 | lld:lifeskim |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C1707491 | lld:lifeskim |
pubmed-article:9307857 | lifeskim:mentions | umls-concept:C1517945 | lld:lifeskim |
pubmed-article:9307857 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:9307857 | pubmed:dateCreated | 1997-10-30 | lld:pubmed |
pubmed-article:9307857 | pubmed:abstractText | In this study the efficacy and safety of calcium heparin administered alone for the prevention of fetal loss related to antiphospholipid antibodies (aPL) were evaluated. | lld:pubmed |
pubmed-article:9307857 | pubmed:language | eng | lld:pubmed |
pubmed-article:9307857 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9307857 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9307857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9307857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9307857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9307857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9307857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9307857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9307857 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9307857 | pubmed:issn | 0392-856X | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:TodescoSS | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:GrellaPP | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:PatrassiG MGM | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:OrsiniAA | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:NardelliG BGB | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:RuffattiAA | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:BrigatoGG | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:Di LenardoLL | lld:pubmed |
pubmed-article:9307857 | pubmed:author | pubmed-author:TrusciaDD | lld:pubmed |
pubmed-article:9307857 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9307857 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:9307857 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9307857 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9307857 | pubmed:pagination | 499-505 | lld:pubmed |
pubmed-article:9307857 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:meshHeading | pubmed-meshheading:9307857-... | lld:pubmed |
pubmed-article:9307857 | pubmed:articleTitle | A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss. | lld:pubmed |
pubmed-article:9307857 | pubmed:affiliation | Chair and Division of Rheumatology, University of Padova, Italy. | lld:pubmed |
pubmed-article:9307857 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9307857 | pubmed:publicationType | Clinical Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9307857 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9307857 | lld:pubmed |